mecamylamine has been researched along with Autonomic Hyperreflexia in 1 studies
Mecamylamine: A nicotinic antagonist that is well absorbed from the gastrointestinal tract and crosses the blood-brain barrier. Mecamylamine has been used as a ganglionic blocker in treating hypertension, but, like most ganglionic blockers, is more often used now as a research tool.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Mecamylamine hydrochloride was initially developed for its ganglion-blocking activity and has been marketed as an antihypertensive agent in the United States for >40 years." | 2.41 | Mecamylamine: new therapeutic uses and toxicity/risk profile. ( George, TP; Sanberg, PR; Shytle, RD; Young, JM, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Young, JM | 1 |
| Shytle, RD | 1 |
| Sanberg, PR | 1 |
| George, TP | 1 |
1 review available for mecamylamine and Autonomic Hyperreflexia
| Article | Year |
|---|---|
Mecamylamine: new therapeutic uses and toxicity/risk profile.
Topics: Animals; Antihypertensive Agents; Area Under Curve; Autonomic Dysreflexia; Central Nervous System; C | 2001 |